Jeremy Shepler

Inspirer
DISC Type : di

Vice president, Global Commercial Leader, Immunology at Johnson & Johnson Innovative Medicine

New York City Metropolitan Area, United States

Overview

Jeremy Shepler is the Vice President and Global Commercial Leader for Immunology at Johnson & Johnson. He is a seasoned marketer with a history of executing successful pre-commercialization and product marketing strategies. He attended Bentley University for his Bachelor of Science.

He is known for leading the commercialization of Ozempic at Novo Nordisk, guiding it to become the fastest chronic disease product to achieve blockbuster status.

Personality Overview

Decisive

Achievment Oriented

Charming & Persuasive

They respond well to objective pitches but also attach some value to relationships.  They measure a product on its merit but can be influenced by strong testimonials. They don’t mind taking a stand if they believe in something.

Topics They Care About

Pharma Commercialization
He has a multifaceted career developing and executing pre-commercialization plans, most notably leading the Ozempic launch to become a blockbuster faster than any other chronic disease product.
Go-to-Market Strategy
He has developed and implemented comprehensive go-to-market strategies at multiple companies, including Galderma and Bryn Pharma, resulting in increased brand visibility and revenue.
Aesthetics Industry
In his recent role as VP of Marketing at Galderma, he aimed to revolutionize the aesthetics industry and grow the company's injectables portfolio.

Media Appearances

Spill the tea on Jeremy Shepler - he's now at Galderma. Featured in Cafepharma Message Boards

See Now

Work History

9-2025
Vice president, Global Commercial Leader, Immunology at Johnson & Johnson Innovative Medicine
6-2024 - 9-2025
Vice president, Marketing Aesthetics at Galderma
5-2023 - 6-2024
SVP Sales and Marketing at Bryn Pharma
1-2023 - 5-2023
Vice President, Area Commerical Lead—East | Cardiometabolic Sales at Novo Nordisk
5-2022 - 5-2023
VP Cardiometabolic Portfolio Strategy and Commercialization at Novo Nordisk

Education

2014 - 2014
Executive leadership program from The Wharton School
1996 - 2000
Bachelor of Science (B.S.) from Bentley University

More Information

Social Presence :

Prographics :

Exp : 13 Location : New York City Metropolitan Area, United States Job Level : Senior Designation : Vice president, Global Commercial Leader, Immunology at Johnson & Johnson Innovative Medicine
URL has been copied!

Insights For Selling To Jeremy

During A Call Or A Meeting

DO's

  • Focus on the big picture and the strategic value of your product
  • Refer to testimonials from well known people to highlight the value of your product
  • Clearly address the competitive aspects

DONT's

  • Don’t keep repeating the same information, it could make them impatient
  • Don’t be very informal even if they are being so themselves
  • Don't be unorganized, be prepared for the pitch

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jeremy is

  • Confidence in the product’s value is critical, followed by relationship and a sense of achievement.
  • Will you ever get a clear answer from Jeremy

  • They will not hesitate to say no if they do not develop conviction.

Insights For Deal Planning

    How fast (or slow) will Jeremy move?

  • If they develop confidence in your product and you, then they can make fast decisions.
  • Can Jeremy take some risk or not?

  • If necessary, they have the ability to take risky decisions.

You And Jeremy

Personality Compatibility


Other Johnson & Johnson Innovative Medicine Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.